Read our oncology team’s summary of ASCO 2024 to learn…
– How LAURA, ADRIATIC, and CROWN are set to reshape lung cancer treatment
– The trials (DESTINY-Breast06) and tribulations (e.g. TROP-2 in NSCLC) surrounding ADCs
– How near (or far) we are from MRD-guided treatment
– A deep dive into the art of cancer care, including PROs, transparency of toxicities, AI advancements, and holistic treatment approaches